About - Dr. Pallavi Redhu

Meet Dr. Pallavi Redhu, an esteemed Oncology(Cancer) with a focus on Oncology(Cancer). Expertise in Oncology and vast experience make the doctor the top choice for exceptional care.

Book an appointment with Dr. Pallavi Redhu

Book an appointment with Dr. Pallavi Redhu today and experience exceptional Dr. Pallavi Redhu care. Book Now!

Location	Phone No.
Kailash Hospital, Sector 27, Noida	+(91)-(0120)-2444444 / 2466666 / 9990444444 (Ambulance)
Kailash Hospital, Greater Noida	+(91)-(0120)2327799 / 09990222222 (Ambulance)
Kailash Hospital, Jewar (U.P.)	05738273333 / 7060255555
Kailash Hospital, Khurja	05738-255555 / 09999998804
Kailash Hospital, Dehradun	0135-2663000 / 2662244
Kailash Hospital & Neuro Institute, Sector 71, Noida	0120-2222222 / 2484444 / 09811223388 (Ambulance)

Dr. Pallavi Redhu

Kailash Hospital & Neuro Institute

Designation : Consultant - Medical Oncology

Speciality : Oncology (Cancer)

Areas of Expertise : Oncology

Qualification : MD, DrNB (Medical Oncology)

Book Appointment

Normal OPD

MONDAY	TUESDAY	WEDNESDAY	THURSDAY	FRIDAY	SATURDAY	SUNDAY
N/A	12:30PM - 2:30PM Book Now	N/A	12:30PM - 2:30PM Book Now	N/A	N/A	N/A

Experience

2023- July 2024 - Consultant Medical Oncologist at Jaypee Hospital,Noida
2022- 2023- Consultant Medical Oncologist at Rajiv Gandhi Cancer Institute and Research center at Delhi
2019 -2022- Senior resident , Department of medical oncology at Rajiv Gandhi Cancer Institute and research center at Delhi
2018-2019- Senior Resident clinical oncology at Delhi state cancer institute
2015- 2018- Junior resident , Department of radiation oncology at Gandhi Medical College , Bhopal.

Membership

Breast cancer
Gynecological cancer (ovarian, uterine,cervical)
Gastrointestinal cancer
Lung cancer
Head and neck cancer
Hematological malignancy- lymphoma, myeloma, chronic leukaemia
Cancer screening and hereditary tumours
Chemotherapy
Hormonal therapy
Cancer vaccination
Immunotherapy and targeted therapy
Precision oncology
Palliative and preventive oncology

Publications

Jain A, Koyyala VP, Narayan S, Soni S, Redhu P, Jaju A. Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy. Indian Journal of Medical and Paediatric Oncology. 2022 Apr;43(02):185-8.
Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World Journal of Clinical Oncology. 2022 May 5;13(5):339.
Agrawal C, Goyal P, Jain P, Domadia K, Redhu P, Doval DC. Colonic polyp-rare site of metastasis from primary lung carcinoma: Clinical presentations and outcome. Lung India: Official Organ of Indian Chest Society. 2021 Nov;38(6):581.
Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VP, Goel V, Batra U, Talwar V. Current Treatment Approaches for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Adjuvant and Neoadjuvant Settings. Indian Journal of Medical and Paediatric Oncology. 2021 Feb;42(01):035-45.
Batra U, Sharma M, Redhu P. Chloroquine and hydroxychloroquine: Clutching at straws in the time of COVID-19?. Cancer Research, Statistics, and Treatment. 2020 Apr 1;3(5):3.
Singh OP, Yogi V, Redhu P, Ghori HU, Pareek A, Lal N. Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer. Journal of cancer research and therapeutics. 2019 Mar 1;15(8):39.
Pareek A, Singh OP, Yogi V, Ghori HU, Tiwari V, Redhu P. Bone metastases incidence and its correlation with hormonal and human epidermal growth factor receptor 2 neu receptors in breast cancer. Journal of Cancer Research and Therapeutics. 2019 Jul 1;15(5):971.
Yogi V, Singh OP, Redhu P, Francis B. Extranodal Non-Hodgkin Lymphomas: The Impact of Different Variables on the Disease. Middle East Journal of Cancer. 2019 Oct 1;10(4):324-32.
SINGH O, Yogi V, Redhu P. Spectrum Of Extranodal Non Hodgkin'S Lymphoma: Evaluation Of Prognostic Factors And Treatment Response. Journal of Cancer Research & Therapeutics. 2017 Dec 2;13.

ORAL & POSTER PRESENTATIONS:

Sharma M, Nathany S, Narayan S, Redhu P, Jain P, Batra U. Real-world data of osimertinib in the management of leptomeningeal metastases in EGFR mutant NSCLC: Light at the end of the tunnel?.
Pallavi Redhu, O.P. Singh, H.U. Ghori, V Yogi. Impact of pelvic irradiation on bone mineral density in cervical cancer patients: Poster Presentation RGCON February 2018
Pallavi Redhu, O. P. singh, H. U. Ghori, V Yogi. Orbital metastases in Ewing’s Sarcoma: A rare cause of Outstanding research work : NBE 2023

Specializes In

Delhi Medical council
European Society of Medical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)
Indian Society of Medical and Pediatric Oncology (ISMPO)

Book Appointment

Get in Touch

Health Packages

Scroll to Top